ASHLEY METZGER: Open Payments
NPI 1932501137 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 52 payments from 16 companies in 2025. Trend: 2023 $539 · 2024 $1,361 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 8 | $229 |
| ABBVIE INC. | 14 | $211 |
| Arcutis Biotherapeutics, Inc. | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $78 |
| Incyte Corporation | 3 | $59 |
| Janssen Biotech, Inc. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Almirall LLC | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $40 |
Products named: BOTOX, Zoryve, OPZELURA, TREMFYA, Sotyktu, Klisyri, DUPIXENT, Cabtreo.
Industry payments across CA — which companies pay providers there.
